Concise Prescribing Info
Listed in Dosage.
Dosage/Direction for Use
Adult: PO Seasonal allergic rhinitis; Chronic idiopathic urticaria 8 mg up to tid.
May be taken with or without food.
Severe renal impairment.
Special Precautions
Patient w/ porphyria, epilepsy. Renal impairment. Elderly. Pregnancy and lactation. Patient Counselling This drug may cause dizziness and somnolence, if affected, do not drive or operate machinery.
Adverse Reactions
Anticholinergic effects, GI disturbance, headache, psychomotor impairment, somnolence, dry mouth, rash, blurred vision, urinary retention. Rarely, dizziness, dyspnoea, angioedema.
Drug Interactions
May produce additional mental depression w/ CNS depressants.
ATC Classification
R06AX18 - acrivastine ; Belongs to the class of other antihistamines for systemic use.
Disclaimer: This information is independently developed by CIMS based on acrivastine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in